Vinge has advised Titania Holding AB (publ) in connection with its listing on Nasdaq First North Growth Market

Vinge has advised Titania Holding AB (publ) (“Titania”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 29 November 2021 and the first day of trading was 10 December 2021.

Vinge has advised Tobii in connection with the listing of Tobii Dynavox

Vinge has advised Tobii and Tobii Dynavox in connection with the distribution of the shares in Tobii Dynavox to the shareholders in Tobii as well as the listing of Tobii Dynavox’s ordinary shares on Nasdaq Stockholm. The prospectus was published 23 November 2021 and the first day of trading on Nasdaq Stockholm was 9 December 2021.

Vinge advises Electra Gruppen in connection with the merger with Elon Group

Electra Gruppen, listed on Nasdaq Stockholm, develops and operates concepts for retail chains with independent entrepreneurs, especially within consumer electronics, and is a flexible logistics partner that offers advanced IT and logistics solutions. Electra Gruppen’s merger with Elon Group creates the leading voluntary specialist retail chain in the Nordic region for home products with a focus on kitchens, appliances, consumer electronics, lighting and interior design, offered to consumers and businesses.

Vinge has advised VNV Global in connection with an investment in Bokadirekt

Vinge has advised VNV Global in connection with its SEK 200 million investment in Bokadirekt.

Vinge advises Cell Impact in connection with its fully guaranteed rights issue of SEK 349 million

Vinge advises Cell Impact AB (publ) in connection with a fully guaranteed rights issue which will provide Cell Impact with gross issue proceeds of SEK 349 million

Vinge has advised SBB in connection with a directed share issue

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with a directed share issue, whereby SBB receives proceeds of approximately MSEK 500.

Vinge advises Trianon on directed share issue

Vinge advises Fastighets AB Trianon (publ) in connection with a directed share issue of approximately SEK 398 million through an accelerated book building procedure.

Vinge advises 24Storage on the public offer from Shurgard

Shurgard Sweden AB has announced a public offer to the shareholders of 24Storage AB (publ). The total value of the offer is approx. SEK 1.075 billion.

Vinge has advised SBB in connection with the sale of properties to a company co-owned with Kåpan

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with the sale of properties for SEK 10 billion to a company co-owned by Kåpan with a focus on government infrastructure.

Vinge has advised VNV Global in connection with a directed share issue

Vinge has advised VNV Global in connection with a directed share issue amounting to approximately SEK 1,191 million at a subscription price of SEK 123 per share.

Vinge advises Norditek in conjunction with its listing on Nasdaq First North

Vinge has advised Norditek Group AB in connection with its listing on Nasdaq First North Growth Market. The first day of trading is 10 November 2021. In connection with the listing, an invitation to subscribe for shares for a subscription price of SEK 11 was implemented, which was significantly oversubscribed by approximately 4.5 times.

Vinge acts as lead advisor to EQT in connection with its acquisition of Life Sciences Partners

Vinge acts as lead advisor to EQT AB in connection with its acquisition of Life Sciences Partners, a leading European life sciences venture capital firm with approximately EUR 2.2 billion of assets under management

Vinge has advised Hexatronic Group AB (publ) in connection with a directed share issue

Vinge has advised Hexatronic Group AB (publ) in connection with a directed share issue whereby the company receives approximately SEK 550 million in gross issue proceeds.

Vinge has advised Tobii AB (publ) in connection with a directed share issue

Vinge has advised Tobii AB in connection with a directed share issue whereby the company receives approximately SEK 300 million in gross issue proceeds.

Vinge has advised Xpray Pharma in connection with share issue

Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinical development listed on Nasdaq Stockholm, in connection with a share issue whereby the company raises proceeds of approximately SEK 100 million.